Corticobasal syndrome and primary progressive aphasia as manifestations of lrrk2 gene mutations.
Ross
Owen A
OA
Toft
Mathias
M
Haugarvoll
Kristoffer
K
D018888:Aphasia, Primary Progressive / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D015984:Causality; D004252:DNA Mutational Analysis / Q000592:standards; D005819:Genetic Markers / Q000235:genetics; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005820:Genetic Testing / Q000592:standards; D014644:Genetic Variation / Q000235:genetics; D005838:Genotype; D006801:Humans; D040582:Inheritance Patterns / Q000235:genetics; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D009154:Mutation / Q000235:genetics*; D019636:Neurodegenerative Diseases / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D009664:Norway; D010300:Parkinson Disease / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D012307:Risk Factors
D005819:Genetic Markers; C495280:LRRK2 protein, human; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; D017346:Protein Serine-Threonine Kinases